Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome

BACKGROUND: Delayed parkinsonism and dystonia are recognized phenomena in osmotic demyelinating syndrome (ODS). Dopamine receptor agonists and levodopa have been reported to benefit select patients. CASE REPORT: We report a patient with ODS with severe pseudobulbar deficits, parkinsonism and dystoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Steve C., Katus, Linn, Frucht, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394193/
https://www.ncbi.nlm.nih.gov/pubmed/32775023
http://dx.doi.org/10.5334/tohm.66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394193/
https://www.ncbi.nlm.nih.gov/pubmed/32775023
http://dx.doi.org/10.5334/tohm.66

Ejemplares similares